Positive surgical margins at radical prostatectomy: Much ado about nothing?

Urologic Oncology: Seminars and Original Investigations

Volumn 31, Issue 3, 2013, Pages 285-287

  Resnick, Matthew J ^a   Cookson, Michael S ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; HUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSTATE CANCER; PROSTATECTOMY; TUMOR VOLUME;

DISEASE PROGRESSION; HUMANS; MALE; PROGNOSIS; PROSTATE; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84875346453     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2011.12.005     Document Type: Article

References (17)

1. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow-up of a randomized clinical trial. J Urol 2009, 181:956-962.
2. Bolla M., van Poppel H., Collette L., et al. Postoperative radiotherapy after radical prostatectomy: A randomized controlled trial (EORTC trial 22911). Lancet 2005, 366:572-578. European Organization for Research and Treatment of Cancer.
3. Wiegel T., Bottke D., Steiner U., et al. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95. J Clin Oncol 2009, 27:2924-2930.
4. Salem S., Chang S.S., Clark P.E., et al. Comparative analysis of whole mount processing and systematic sampling of radical prostatectomy specimens: Pathological outcomes and risk of biochemical recurrence. J Urol 2010, 184:1334-1340.
5. Tan P.H., Cheng L., Srigley J.R., et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working Group 5: Surgical margins. Modern pathology: An Official Journal of the United States and Canadian Academy of Pathology, Inc 2011, 48-57. ISUP Prostate Cancer Group.
6. Montironi R., Cheng L., Mazzucchelli R., et al. Pathological definition and difficulties in assessing positive margins in radical prostatectomy specimens. BJU Int 2009, 103:286-288.
7. Stephenson A.J., Wood D.P., Kattan M.W., et al. Location, extent and number of positive surgical margins do not improve accuracy of predicting prostate cancer recurrence after radical prostatectomy. J Urol 2009, 182:1357-1363.
8. Alkhateeb S., Alibhai S., Fleshner N., et al. Impact of positive surgical margins after radical prostatectomy differs by disease risk group. J Urol 2010, 183:145-150.
9. Wright J.L., Dalkin B.L., True L.D., et al. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality. J Urol 2010, 183:2213-2218.
10. Boorjian S.A., Thompson R.H., Tollefson M.K., et al. Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: The impact of time from surgery to recurrence. Eur Urol 2011, 59:893-899.
11. Savdie R., Horvath L.G., Benito R.P., et al. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy. BJU Int 2011 Oct 12, [Epub ahead of print].
12. Resnick M.J., Canter D.J., Guzzo T.J., et al. Defining pathological variables to predict biochemical failure in patients with positive surgical margins at radical prostatectomy: Implications for adjuvant radiotherapy. BJU Int 2010, 105:1377-1380.
13. van der Kwast T.H., Bolla M., van Poppel H., et al. Identification of patients with prostate cancer who benefit from immediate postoperative radiotherapy: EORTC 22911. J Clin Oncol 2007, 25:4178-4186.
14. Stephenson A.J., Scardino P.T., Kattan M.W., et al. Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy. J Clin Oncol 2007, 25:2035-2041.
15. Trock B.J., Han M., Freedland S.J., et al. Prostate cancer-specific survival following salvage radiotherapy vs. observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008, 299:2760-2769.
16. Stephenson A.J., Shariat S.F., Zelefsky M.J., et al. Salvage radiotherapy for recurrent prostate cancer after radical prostatectomy. JAMA 2004, 291:1325-1332.
17. Showalter T.N., Foley K.A., Jutkowitz E., et al. Costs of early adjuvant radiation therapy after radical prostatectomy: A decision analysis. Ann Oncol 2011 Jun 9, [Epub ahead of print].